Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-25-002716

Director sold 959 shares at $21.00 ($20,139)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
OLUKOTUN ADEOYE Y Director 2025-01-23 Sale 10b5-1 −959 $21.00 $20,139 35,781 D
Open-market sales · 959 sh · avg $21.00 · $20,139
Loading xslF345X05/wk-form4_1738023770.xml…